A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma
Bhatia, Shailender, Pavlick, Anna C., Boasberg, Peter, Thompson, John A., Mulligan, George, Pickard, Michael D., Faessel, Hélène, Dezube, Bruce J., Hamid, OmidVolume:
34
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-016-0348-5
Date:
August, 2016
File:
PDF, 515 KB
english, 2016